Literature DB >> 3325714

The MOPC-315 tumor as a model for the immunomodulatory effects of cyclophosphamide.

M B Mokyr1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3325714

Source DB:  PubMed          Journal:  Methods Find Exp Clin Pharmacol        ISSN： 0379-0355


× No keyword cloud information.
  4 in total

1.  Influence of low doses of an oxazaphosphorine on natural killer activity of human lymphocytes.

Authors:  H Blomgren
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Possible role of acrolein in oxazaphosphorine-induced enhancement of immunological reactivity.

Authors:  H Blomgren; M Hallström
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

3.  Effects of rotational stress on the effectiveness of cyclophosphamide and razoxane in mice bearing Lewis lung carcinoma.

Authors:  L Perissin; S Zorzet; P Piccini; V Rapozzi; T Giraldi
Journal:  Clin Exp Metastasis       Date:  1991 Nov-Dec       Impact factor: 5.150

4.  Inhibition of T suppressor cell function by local administration of an active cyclophosphamide derivative at the sensitization site.

Authors:  J Limpens; R J Scheper
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.